BSP Pharmaceuticals S.p.a

CDMO based in Latina, Italy, specializing in cytotoxic and non-cytotoxic oncology and immunotherapy drugs. Handles small molecules, biologics, ADCs, peptides and oligonucleotides. Investing EUR 530M in expansion (2024-2028) to reach 2,800 kg mAb/year capacity.